📰 Global External News
Page 4 - Global External News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Global External. Real-time updates on events, politics, business and more.
May 4, 2023
Daix , Long Island City , May 4, 2023 – Inventiva , a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with... | May 4, 2023
May 4, 2023
Daix (France), Long Island City (New York, United States), May 4, 2023 - Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small
March 30, 2023
Daix (France), Long Island City (New York, United States), March 30, 2023 Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral
March 30, 2023
Daix , Long Island City , March 30, 2023 Inventiva , a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic... | March 30, 2023
March 29, 2023
Investegate announcements from INVENTIVA, Inventiva reports its 2022 full-year results
March 29, 2023
Cash and cash equivalents at €86.7 million and short term deposits at €1 million as of December 31, 2022 compared to €86.6 million and €8.8 million, respectively as of December 31, 2021 Inventiva
March 23, 2023
Daix , Long Island City , March 23, 2023 – Inventiva , a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with... | March 23, 2023
March 23, 2023
Daix (France), Long Island City (New York, United States), March 23, 2023 - Inventiva (Euronext Paris and Nasdaq: IVA) (the "Company"), a clinical-stage biopharmaceutical company focused on the development
March 23, 2023
Investegate announcements from INVENTIVA, Inventiva announces the schedule of publication and presentation of its 2022 Full-Year Financial Results
February 14, 2023
Daix (France), Long Island City (New York, United States), February 14, 2023 - Inventiva (Euronext Paris and Nasdaq: IVA) (the "Company"), a clinical-stage biopharmaceutical company focused on the development